Precision Genomics Collaboratory News

Before breakthrough research at Duke led to the first FDA-approved treatment in 2006, infants diagnosed with Pompe disease rarely survived more than a year or two. Now many are growing up and thriving. Under the leadership of Priya Kishanani, MD, Duke is continuing to explore new approaches that will give life and hope to even more families.

A biotech startup with ties to Duke University is expanding after closing a $7.5 million raise.

Amy Goldberg’s passion for human evolution probably started with the genetic anthropology books her father poured over during his Ph.D. studies.

Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Duke’s collective strengths in research, clinical care, and popul

Noncoding RNAs are proving to be critical players in the evolution of brain anatomy and cognitive complexity.

Makenzie Beaman, a pediatric scientist in training in the Medical Science Training Program (MSTP), was selected for the best fellow platform presentation award at the 43rd Annual David W. Smith Workshop on Malformations and Morphogenesis on August 23. 

Out of the 64 fellows and medical genetics residents and fellows in the workshop, 13 were selected to give platform presentations. Beaman and one other were selected as the co-best presentation. 

Microbial proteins around a sexually transmitted infection allow pathogen to hide undetected inside host cells

Microbial communities can vary drastically, but despite the variations, certain functions in these microbial communities stay stable, and now researchers at Duke are understanding why.

How a group of genome sequencing research scientists at Duke steered the university's COVID-19 response.

New $26 million center will work to understand and engineer the microbiomes in our homes, workspaces and other built environments